(Q42013229)

15 October 2017

Application of a trifunctional reactive linker for the construction of antibody-drug hybrid conjugates (English)

1 reference

15 October 2017

3

Christoph Rader

1 reference

15 October 2017

Joshua D Thomas

1

1 reference

15 October 2017

Thomas Hofer

series ordinal

2

1 reference

15 October 2017

Terrence R Burke

series ordinal

4

1 reference

15 October 2017

language of work or name

English

0 references

publication date

14 October 2008

1 reference

Bioorganic & Medicinal Chemistry Letters

15 October 2017

1 reference

15 October 2017

18

1 reference

15 October 2017

21

1 reference

15 October 2017

5785-5788

1 reference

An engineered selenocysteine defines a unique class of antibody derivatives

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461582

Highly potent, water soluble benzimidazole antagonist for activated alpha 4 beta 1 integrin

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461582

Technology insight: cytotoxic drug immunoconjugates for cancer therapy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461582

Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461582

Arming antibodies: prospects and challenges for immunoconjugates

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461582

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461582

Anti-alpha4 integrin monoclonal antibody inhibits multiple myeloma growth in a murine model.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461582

Synthesis of hydrophilic and flexible linkers for peptide derivatization in solid phase

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461582

Chemically programmed monoclonal antibodies for cancer therapy: adaptor immunotherapy based on a covalent antibody catalyst.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461582

alpha 4 integrins and tumor metastasis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461582

Chemically programmed antibodies: endothelin receptor targeting CovX-Bodies.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461582

Integrin alpha4beta1 promotes monocyte trafficking and angiogenesis in tumors.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461582

Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461582

Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461582

Multimeric cyclic RGD peptides as potential tools for tumor targeting: solid-phase peptide synthesis and chemoselective oxime ligation

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461582

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461582

Automated synthesis of N-bromoacetyl-modified peptides for the preparation of synthetic peptide polymers, peptide-protein conjugates, and cyclic peptides

30 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18922692

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effector

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18922692

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.BMCL.2008.09.078

1 reference

15 October 2017

1 reference

15 October 2017

PubMed publication ID

18922692

1 reference